XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis

被引：0
作者：
Fanghui Ye
Zhenfang Liu
Aihua Tan
Ming Liao
Zengnan Mo
Xiaobo Yang
机构：
[1] Guangxi Medical University,Center for Genomic and Personalized Medicine
[2] Guangxi Medical University,Department of Hematology, The First Affiliated Hospital
[3] Guangxi Medical University,Department of Chemotherapy, The Affiliated Tumor Hospital
[4] Guangxi Medical University,Institute of Urology and Nephrology, The First Affiliated Hospital
[5] Guangxi Medical University,Department of Occupational Health and Environmental Health, School of Public Health
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Oxaliplatin; Colorectal cancer; Genetic polymorphisms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 740
页数：7
相关论文
共 50 条
  • [1] XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis
    Ye, Fanghui
    Liu, Zhenfang
    Tan, Aihua
    Liao, Ming
    Mo, Zengnan
    Yang, Xiaobo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 733 - 740
  • [2] Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
    Huang, Zhao-Hui
    Hua, Dong
    Du, Xiang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 1001 - 1007
  • [3] Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
    Zhao-Hui Huang
    Dong Hua
    Xiang Du
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 1001 - 1007
  • [4] XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis
    Wang, Bin
    Wang, Dan
    Huang, Gang
    Zhang, Chao
    Xu, Dong-hua
    Zhou, Weiping
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (03) : 313 - 321
  • [5] XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis
    Bin Wang
    Dan Wang
    Gang Huang
    Chao Zhang
    Dong-hua Xu
    Weiping Zhou
    International Journal of Colorectal Disease, 2010, 25 : 313 - 321
  • [6] A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk
    Jiang, Zheng
    Li, Chunxiang
    Xu, Ye
    Cai, Sanjun
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (02) : 169 - 180
  • [7] A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk
    Zheng Jiang
    Chunxiang Li
    Ye Xu
    Sanjun Cai
    International Journal of Colorectal Disease, 2010, 25 : 169 - 180
  • [8] The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Jun Liang
    Tao Jiang
    Ru-yong Yao
    Zi-min Liu
    Hong-ying Lv
    Wei-wei Qi
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 493 - 500
  • [9] The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Liang, Jun
    Jiang, Tao
    Yao, Ru-yong
    Liu, Zi-min
    Lv, Hong-ying
    Qi, Wei-wei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 493 - 500
  • [10] Chemotherapeutic Responsibility according to Polymorphism of ERCC1, XRCC1 and GSTP1 in Gastric Cancer Patients Receiving Oxaliplatin Based Chemotherapy
    Won, Dae Youn
    Kim, Soo Hong
    Hur, Hoon
    Jung, Hun
    Jeon, Hae Myung
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 78 (06): : 350 - 356
12345